Ilumina (NASDAQ:ILMN) files a lawsuit in the U.S. District Court for the Northern District of California against Roche (OTCQX:RHHBY) subsidiary Ariosa Diagnostics accusing it of infringing on U.S. Patent No. 7,955,794 entitled "Multiplex Nucleic Acid Reactions." The action is focused on Ariosa's Microarray-based version of its Harmony Prenatal Test.
Previously, Ilumina and its subsidiary Verinata Health filed suits in the same court accusing Ariosa of infringing the '794 patent as well as Patent Nos. 8,296,076 and 8,318,430 with the sequencing-based version of its Harmony Prenatal T
Mitchell Johnson
unread,
May 18, 2015, 7:05:36 PM5/18/15
Reply to author
Sign in to reply to author
Forward
Sign in to forward
Delete
You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to the-sequenom-d...@googlegroups.com
Pathetic! They have the reverse Midas touch. The world's worst run company. They are business so that their hedge fund friends can score big by shorting this puppy.